DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens  of various pathogens as genetically engineered vaccines  both  preventive and ther...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov
Format: article
Langue:RU
Publié: SPb RAACI 2017
Sujets:
Accès en ligne:https://doaj.org/article/873ea27afa2e4dde939b3d79061df97c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!